FFO per share was flat year-over-year despite higher net income, as the net income increase came from a nonrecurring depreciation comparison. The Miller Medical Plaza completion in December 2026 could add lease revenue in 2027, but near-term growth catalysts are limited. Monitor the Q4 2026 land sale gain and any update on the MOB lease-up.
Price Chart
Executive Summary
Universal Health Realty Income Trust reported Q3 2026 net income of $4.9M ($0.35/diluted share) vs $4.0M ($0.29) a year ago, a $913K increase driven largely by a nonrecurring depreciation expense in Q3 2025. FFO was essentially flat at $12.3M ($0.88/share) vs $12.2M ($0.88) in Q3 2025. Total revenue was $25.3M, slightly above the $24.9M consensus estimate, but the FFO per share was unchanged year-over-year, indicating no underlying operational growth.
Key Financial Metrics
Key Facts
- Q3 2026 net income $4.9M ($0.35/diluted) vs $4.0M ($0.29) in Q3 2025
- FFO $12.3M ($0.88/diluted) vs $12.2M ($0.88) in Q3 2025, essentially flat
- Total revenue $25.3M vs $25.3M in Q3 2025, flat year-over-year
- Revenue slightly above consensus estimate of $24.9M
- Quarterly dividend increased to $0.75/share from $0.74 in Q3 2025
- Credit line borrowings rose to $377.7M from $356.2M at year-end 2025
- Sold Chicago land parcel in October 2026 for $1.96M net proceeds, expecting ~$1.9M gain in Q4
- Miller Medical Plaza construction expected to complete in December 2026 at ~$34M cost
Financial Impact
Revenue flat YoY at $25.3M; FFO per share unchanged at $0.88; net income up $0.9M due to nonrecurring prior-year depreciation
Risk Factors
- Flat FFO per share signals no organic earnings growth
- Credit line borrowings increased to $377.7M, reducing available capacity to $97.3M
- Interest rate sensitivity: higher rates could further increase borrowing costs
- Tenant concentration risk: significant revenue from UHS facilities
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-434277 |
| Document: uht-20261027.htm | 0001193125-26-434277 |
| Document: 0001193125-26-434277-index-headers.html | 0001193125-26-434277 |
| Document: 0001193125-26-434277-index.html | 0001193125-26-434277 |
| Document: 0001193125-26-434277.txt | 0001193125-26-434277 |
| 8-K Data (Synthetic) | 0001193125-26-434277 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 5d ago | 8-K | $36.76 | awaiting T+60 | awaiting T+60 | $38.25 (+4.05%) |
Apr 28, 2026 26w ago | DEFA14A | $40.80 $43.29 | ▲ +6.10% | ▲ +2.11% | $38.25 (−6.25%) |
Apr 27, 2026 26w ago | 8-K | $40.80 $43.29 | ▲ +6.10% | ▲ +2.11% | $38.25 (−6.25%) |
Apr 24, 2026 27w ago | 8-K | $40.77 $43.88 | ▲ +7.63% | ▲ +2.55% | $38.25 (−6.18%) |
Feb 25, 2026 35w ago | 8-K | $43.38 $42.12 | ▲ +2.90% | ▲ +10.65% | $38.25 (+11.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers